Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1581 Dodd Dr
Fl 4
Columbus, OH 43210Phone+1 614-293-4854Fax+1 614-293-8102
Education & Training
- Tulane UniversityPost-Doctoral Fellowship, Infectious Disease, 2004 - 2005
- Louisiana State University School of MedicineFellowship, Infectious Disease, 2002 - 2004
- University of Wisconsin Hospitals and ClinicsFellowship, Infectious Disease, 2000 - 2001
- Medical College of WisconsinClass of 1996
Certifications & Licensure
- OH State Medical License 2005 - 2025
- WI State Medical License 1997 - 2007
- LA State Medical License 2002 - 2006
- CA State Medical License Active through 1998
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study) Start of enrollment: 2019 Nov 04
Publications & Presentations
PubMed
- Impact of the elderly lung mucosa ontranscriptional adaptation during infection of alveolar epithelial cells.Angélica M Olmo-Fontánez, Anna Allué-Guardia, Andreu Garcia-Vilanova, Jeremy Glenn, Shu-Hua Wang
Microbiology Spectrum. 2024-11-08 - Applicability of selected Brighton Collaboration case definitions in low-resource settings: A prospective hospital-based active surveillance in Addis Ababa, Ethiopia.Kassech Sintayehu, Anna Shaum, Zelalem Tazu Bonger, Eden Dagnachew Zeleke, Biniyam Tedla Mamo
Vaccine. 2024-10-24 - 1 citationsFactors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021.Abyot Bekele Woyessa, Monica P Shah, Binyam Moges Azmeraye, Jeff Pan, Leuel Lisanwork
Vaccines. 2024-07-11
Press Mentions
- Ohio State Zeroes in on Improving Bovine Tuberculosis TestingJuly 31st, 2019
- High Completion Rate for Isoniazid-Rifapentine in Patients with Latent TBOctober 9th, 2017
- With Short Course of TB Prevention for People Living with HIV, Completion SoarsAugust 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: